NRX Pharmaceuticals

Yahoo Finance • 4 days ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamineGranting of Suitability Petition enables re-filing of Abbreviated New Drug Application (ANDA) for NRx’s patent... Full story

Yahoo Finance • 20 days ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Dura Medical, together with pending acquisitions of Neurospa TMS and Cohen & Associates, to provide contiguous coverage at more than 8 locations along Florida’s West Coast, with planned coverage throughout the Florida PeninsulaDura deliver... Full story

Yahoo Finance • 25 days ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"),... Full story

Yahoo Finance • 26 days ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller.Company has rec... Full story

Yahoo Finance • 26 days ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller.Company has rec... Full story

Yahoo Finance • last month

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

US Food and Drug Administration (FDA) has granted Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression.NRx Pharmaceuticals is making NRX-100 available on an expa... Full story

Yahoo Finance • last month

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need.Represents an approximately 1... Full story

Yahoo Finance • 2 months ago

NRx Pharma: FDA Grants Fast Track Designation For NRX-100

(RTTNews) - NRx Pharmaceuticals (NRXP) announced FDA has granted Fast Track designation to NRX-100 for the treatment of suicidal ideation in patients with depression, including bipolar depression. FDA made the determination that NRX-100 ha... Full story

Yahoo Finance • 2 months ago

HOPE Therapeutics receives Florida approval for Dura Medical acquisition

MIAMI - HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a small-cap pharmaceutical company with a market capitalization of approximately $48 million, announced Friday it has received final clearance from Florida... Full story

Yahoo Finance • 3 months ago

NRx Pharmaceuticals files $150M mixed shelf offering

* NRx Pharmaceuticals (NASDAQ:NRXP [https://seekingalpha.com/symbol/NRXP]) has filed a shelf registration to offer up to $150M in securities over time. * Securities may include common stock, preferred stock, debt securities, depositary... Full story

Yahoo Finance • 3 months ago

New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NAS

The show is sponsored by The Sustainable Green Team’s (OTC:SG™) Waterless Garden NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / New to The Street, the nation’s leading financial television series, announces the nationwide broadcast... Full story

Yahoo Finance • 3 months ago

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST

Featured as Sponsored Programming: FLOKI, BioVie Inc. (NASDAQ:BIVI), NRX Pharmaceuticals (NASDAQ:NRXP), and Vita Bella NEW YORK CITY, NEW YORK / ACCESS Newswire / June 16, 2025 / New to The Street, a premier financial media platform, anno... Full story

Yahoo Finance • 3 months ago

New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ:

This week’s episode is sponsored by The Sustainable Green Team’s Waterless Garden (OTC:SG™) and PetVivo Holdings, Inc.’s (NASDAQ:PETV) innovative SPRYNG™ product. NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / New to The Street, th... Full story

Yahoo Finance • 4 months ago

NRx Pharma Submits ANDA For Preservative-free IV Ketamine

(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP), Thursday said it has submitted Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for preservative-free IV ketamine formulation, NRX-100, for all approved u... Full story

Yahoo Finance • 2 years ago

STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Investors to Contact the Firm

PHILADELPHIA, July 10, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (“NRx”) on behalf of the company’s long-term shareholders. NRx is a clinical-stage pharmaceutica... Full story